Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-005012
Filing Date
2025-07-15
Accepted
2025-07-15 16:12:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4532
  Complete submission text file 0001950047-25-005012.txt   5977
Mailing Address 655 MONTGOMERY STREET SUITE 1500 SAN FRANCISCO CA 94111
Business Address 655 MONTGOMERY STREET SUITE 1500 SAN FRANCISCO CA 94111 (415) 432-9270
89bio, Inc. (Subject) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39122 | Film No.: 251124899
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address
Le-Nguyen Quoc (Reporting) CIK: 0001792062 (see all company filings)

Type: 144